Kakeji, Yoshihiro http://orcid.org/0000-0002-2727-0241
Yoshida, Kazuhiro
Kodera, Yasuhiro
Kochi, Mitsugu
Sano, Takeshi
Ichikawa, Wataru
Lee, Sang-Woong
Shibahara, Kazushige
Shikano, Toshio
Kataoka, Masato
Ishiguro, Atsushi
Ojima, Hitoshi
Sakai, Yoshinori
Musha, Nobuyuki
Takase, Tsunenobu
Kimura, Taisei
Takeuchi, Masahiro
Fujii, Masashi
Article History
Received: 21 June 2021
Accepted: 26 July 2021
First Online: 5 August 2021
Declarations
:
: Yoshihiro Kakeji reports grants and personal fees from Taiho Pharma, Tsumura, Abbott, Chugai Pharma, Sanofi, Nippon Kayaku, Kaken Pharma, Lilly Japan, Takeda Pharma, Terumo Corp., Astellas Pharma, Otsuka Pharma Factory, Ono Pharma, personal fees from Bayer, MSD, Daiichi Sankyo, Miyarisan Pharma, Merck, Bristol-Myers squibb, Olympus, Covidien, Yakult Honsha, Johnson & Johnson, EA Pharma, Fluidigm, outside the submitted work. Kazuhiro Yoshida reports grants and personal fees from Sanofi, Taiho Pharm., during the conduct of the study; grants and personal fees from Asahi Kasei Pharma, Chugai Pharma, Covidien Japan, Daiichi Sankyo, Eli Lilly Japan, Johnson & Johnson, Merk Serono, MSD, Nippon Kayaku, Novartis Pharma, Ono Pharm., Otsuka Pharm., Takeda Pharm., TERUMO, Tsumura & Co., Yakult Honsha, Abbott, grants from Abbvie, Astellas, Biogen Japan, Celgene, Eisai, EP‐CRSU, EPS Corporation, FUJIFILM, GlaxoSmithKline K.K., Kaken Pharm., Kyowa Kirin, Meiji Seika Pharma, Philips, Toray Medical, personal fees from AstraZeneka, Bristol-Myers Squibb Japan, Denka Co., Ltd, EA Pharma, Olympus, Pfizer, Sanwa Kagaku Kenkyusho, SBI Pharma, Teijin Phamra, outside the submitted work. Yasuhiro Kodera reports grants from Kaken Pharma, Covidien, EA Pharma, Novartis, KCI, Maruho, Otsuka, Sawai, Sanofi, Shionogi, Nihon Kayaku, grants and personal fees from Daiichi Sankyo, Tsumura, Taiho Pharma, Chugai Pharma, Lilly Japan, Johnson & Johnson, Takeda, Yakult, Otsuka, Ono Pharma, Covidien, MSD, personal fees from Bristol, outside the submitted work. Wataru Ichikawa reports grants and personal fees from Chugai Pharma, Taiho Pharma, Takeda Pharma, Daiichi Sankyo, Merck Pharma, Ono Pharma, grants from Eli Lilly Japan, personal fees from Yakult Honsha, Bayer Yakuhin, Eizai, Shionogi, AstraZeneca, Bristol Myers Squibb, Nippon Kayaku, AstraZeneca K.K, outside the submitted work. The other authors declare that they have no conflicts of interest.
Free to read: This content has been made available to all.